Akèy › Artrit Rematoid
Etid klinik pou Artrit Rematoid ap rekrite nan Etazini
57 etid pou Artrit Rematoid ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX11 etid
- New York City, NY10 etid
- Durham, NC8 etid
- Altoona, PA7 etid
- Dallas, TX7 etid
- Aurora, CO7 etid
- Boston, MA7 etid
- San Diego, CA6 etid
- Plantation, FL6 etid
- Chicago, IL6 etid
- Mesquite, TX5 etid
- Miami, FL5 etid
- West Palm Beach, FL5 etid
- Ann Arbor, MI5 etid
- Portland, OR4 etid
- Tucson, AZ4 etid
- Charlotte, NC4 etid
- Cicero, IL4 etid
- Arlington, TX4 etid
- Clearwater, FL4 etid
- Gainesville, FL4 etid
- The Woodlands, TX4 etid
- St. Louis, MO4 etid
- Lake Charles, LA4 etid
- Mountain View, CA4 etid
- Coral Springs, FL4 etid
- West Covina, CA3 etid
- Austin, TX3 etid
- Kendall, FL3 etid
- Cedar Rapids, IA3 etid
- Anniston, AL3 etid
- Omaha, NE3 etid
- Jackson, TN3 etid
- Los Angeles, CA3 etid
- Jacksonville, FL3 etid
- Tampa, FL3 etid
- Denver, CO3 etid
- Baltimore, MD3 etid
- Pittsburgh, PA3 etid
- Hollywood, FL3 etid
Pa eta
- Alabama5 etid
- Arizona9 etid
- Colorado10 etid
- Florid21 etid
- Georgia4 etid
- Illinois12 etid
- Iowa3 etid
- Kalifòni23 etid
- Kansas3 etid
- Lwizyàn5 etid
- Maryland4 etid
- Massachusetts8 etid
- Michigan9 etid
- Minnesota4 etid
- Missouri4 etid
- Nebraska3 etid
- New Jersey3 etid
- New York15 etid
- North Carolina12 etid
- Ohio7 etid
- Oregon4 etid
- Pennsylvania10 etid
- South Carolina5 etid
- Tennessee5 etid
- Texas16 etid
- Virginia6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06631638A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07607964RA-PRO PRAGMATIC TRIAL
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04692493Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07412704A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06972446A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07137598An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07620392Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 18, 2026 · NCT07201558Exactech Shoulder Post Market Clinical Follow-up Study
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05603728A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 15, 2026 · NCT06916806FT839 in Autoimmune Diseases
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT07800871A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 21, 2026 · NCT06570798Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 19, 2026 · NCT05277025Phase 1b/2 Study of IV Sarilumab in Adult With RA
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07704580Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Aug 10, 2026 · NCT07180537A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07295847Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jul 20, 2026 · NCT07237659The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Ap rekriteEtid obsèvasyon
Laj 35 a 79 · Tout sèks · Mizajou Jul 14, 2026 · NCT07315997A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745Early Rheumatoid Arthritis Lung Disease Study
Ap rekriteEtid obsèvasyon
Laj 19 a 90 · Tout sèks · Mizajou Jul 9, 2026 · NCT03192267Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07138898Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07293871Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.